Literature DB >> 30503855

Views from the clinic: Healthcare provider perspectives on whole genome sequencing in paediatrics.

M J Szego1, M S Meyn2, C Shuman3, R Zlotnik Shaul4, J A Anderson5, S Bowdin2, N Monfared6, R Z Hayeems7.   

Abstract

Whole genome sequencing (WGS) is a transformative technology which promises improved diagnostic rates compared to conventional genetic testing strategies and tailored approaches to patient care. Due to the practical and ethical complexities associated with using WGS, particularly in the paediatric context, input from a broad spectrum of healthcare providers can guide implementation strategies. We recruited healthcare providers from the largest paediatric academic health science centre in Canada and conducted semi-structured qualitative interviews, exploring experiences with and perceptions of the opportunities and challenges associated with WGS. Interview transcripts were coded and analyzed thematically. Interviews were completed with 14 genetics professionals (geneticists and genetic counsellors) and 15 non-genetics professionals (physician sub-specialists and nurses). Genetics professionals ordered genetic tests more often and reported greater confidence on pre- and post-test genetic counselling compared to non-genetics professionals. Most healthcare providers endorsed WGS when a more specific test was either not available or not likely to yield a diagnosis. While genetics professionals raised concerns regarding the time demands associated with reviewing WGS variants, non-genetics professionals reflected concerns about knowledge and training. Providers' position on reporting secondary variants to parents drew upon but was not limited to the concept of best interests. Taken together, understanding practical and principled matters of WGS from healthcare providers' perspectives can guide ongoing efforts to implement WGS in paediatrics.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Best interests; Paediatrics; Secondary findings; Whole genome sequencing

Mesh:

Year:  2018        PMID: 30503855     DOI: 10.1016/j.ejmg.2018.11.029

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  4 in total

1.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).

Authors:  David T Miller; Kristy Lee; Adam S Gordon; Laura M Amendola; Kathy Adelman; Sherri J Bale; Wendy K Chung; Michael H Gollob; Steven M Harrison; Gail E Herman; Ray E Hershberger; Teri E Klein; Kent McKelvey; C Sue Richards; Christopher N Vlangos; Douglas R Stewart; Michael S Watson; Christa Lese Martin
Journal:  Genet Med       Date:  2021-05-20       Impact factor: 8.822

2.  Parental Attitudes Toward Clinical Genomic Sequencing in Children With Critical Cardiac Disease.

Authors:  Dana B Gal; Natalie Deuitch; Sandra Soo Jin Lee; Rosalie Tang Simon; Danton S Char
Journal:  Pediatr Crit Care Med       Date:  2021-08-01       Impact factor: 3.971

3.  Return of genetic and genomic research findings: experience of a pediatric biorepository.

Authors:  Tanya Papaz; Eriskay Liston; Laura Zahavich; Dimitri J Stavropoulos; Rebekah K Jobling; Raymond H Kim; Miriam Reuter; Anastasia Miron; Erwin Oechslin; Tapas Mondal; Lynn Bergin; John F Smythe; Luis Altamirano-Diaz; Jane Lougheed; Roderick Yao; Oyediran Akinrinade; Jeroen Breckpot; Seema Mital
Journal:  BMC Med Genomics       Date:  2019-11-27       Impact factor: 3.063

4.  Comprehensive Genetic Testing for Pediatric Hypertrophic Cardiomyopathy Reveals Clinical Management Opportunities and Syndromic Conditions.

Authors:  Dana B Gal; Ana Morales; Susan Rojahn; Tom Callis; John Garcia; James R Priest; Rebecca Truty; Matteo Vatta; Robert L Nussbaum; Edward D Esplin; Seth A Hollander
Journal:  Pediatr Cardiol       Date:  2021-10-29       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.